Status:
COMPLETED
Multi-arm Intervention Diabetes Adherence Study
Lead Sponsor:
Henry Ford Health System
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the effectiveness of two different interventions to improve adherence to diabetes medications among patients with diabetes and poor metabolic control.
Detailed Description
Nonadherence to medications is common among patients with diabetes and contributes to suboptimal control of glycemic and lipid plasma levels. Adherence is not routinely measured in clinical practice b...
Eligibility Criteria
Inclusion
- At least 2 dispensings for oral medications used to treat diabetes and dyslipidemia in the last 18 month.
- At least one laboratory result for both glycated hemoglobin and LDL-cholesterol in the last 6 months.
- Average HbA1c ≥ 7% OR an average LDL ≥ 100 mg/d
- Continuous health plan enrollment currently and in the previous calendar year with no more than a 1 month lapse of coverage, and benefits that include both medical and pharmacy coverage.
Exclusion
- Patients who have been institutionalized in a nursing home or in a long-term care facility for more than 3 months in the preceding 18 month period.
- Participation in a disease management program
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
1692 Patients enrolled
Trial Details
Trial ID
NCT00754741
Start Date
July 1 2008
End Date
December 1 2012
Last Update
May 8 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health System
Detroit, Michigan, United States, 48202